Global Hospital-Acquired Infection Diagnostics Market Size By Test Type (Molecular Diagnostics, Urinalysis), By Infection Type (Bloodstream Infection, Urinary Tract Infection), By Application (Disease Testing, Drug Resistance Testing), By Geographic Scope And Forecast

Hospital-Acquired Infection Diagnostics Market Size And Forecast

Hospital-Acquired Infection Diagnostics Market size was valued at USD 5.07 Billion in 2021 and is projected to reach USD 9.01 Billion by 2030, growing at a CAGR of 6.70% from 2023 to 2030.

The rising geriatric population base is one of the key factors for the growth of the Global Hospital-Acquired Infection Diagnostics Market because the advancing age of the geriatric population makes them more susceptible to diseases. The present need of the time is an immediate diagnosis of an infectious disease due to evolving pathogens and the increasing occurrence of hospital-acquired diseases. Moreover, the COVID-19 pandemic has majorly contributed to the demand for point-of-care immunodiagnostic tests. The Global Hospital-Acquired Infection Diagnostics Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Hospital-Acquired Infection Diagnostics Market Definition

Patients admitted to hospitals or healthcare facilities for different diseases can acquire hospital-acquired infection also known as nosocomial infection. All kinds of patients from children to elderly ones, who have undergone surgery, are prone to such infections. The most common infections are gastrointestinal infection, surgical-site infection, respiratory infection, bloodstream infection, urinary tract infection, bone and joint infection, and cardiovascular system infections.

An infection or toxin that exists in a certain location such as a hospital which can be contacted by a patient who visited or is admitted to the hospital for any other reason apart from this infection is known as a Nosocomial infection or hospital-acquired infection. Intensive care units or ICUs are the most common words where HAIs occur as doctors treat serious diseases there.

Global Hospital-Acquired Infection Diagnostics Market Overview

The major drivers boosting the growth of the Global Hospital-Acquired Infection Diagnostics Market are the rising geriatric population base, the development of technologically advanced diagnostic products, and the demand for HAI diagnostics from middle and low-income countries. Other factors contributing to the growth are an increase in awareness about hospital-acquired infections, the surge in R&D spending, improved healthcare infrastructure, technological advancements, and increased government initiatives across the world.

Government and non-profit organizations have introduced many awareness programs to reduce the loss of lives across the world due to hospital-acquired infections, which is expected to provide ample opportunities for the growth of the Global Hospital-Acquired Infection Diagnostics Market. Furthermore, an awareness program named Patient Safety Solutions is introduced by World Health Organization to promote hand hygiene adherence as a healthcare facility on priority to prevent hospital-acquired infections. Despite the various opportunities for growth of the Global Hospital-Acquired Infection Diagnostics Market, there are a few factors that may restrain the growth of the market, such as a lack of awareness about HAI in low- and middle-income economies and the decreasing prevalence of nosocomial infections in the developed countries.

Global Hospital-Acquired Infection Diagnostics MarketSegmentation Analysis

The Global Hospital-Acquired Infection Diagnostics Market is segmented on the basis of Test Type, Infection Type, Application, and Geography.

Hospital-Acquired Infection Diagnostics Market, By Test Type

• Molecular Diagnostics
• Urinalysis
• Immunoassay

Based on Test Type, the market is segmented into Molecular Diagnostics, Urinalysis, and Immunoassay. Molecular Diagnostics held the largest share in the market in 2020 and is expected to grow with a high CAGR because of the advantages such as the detection of lower amounts of infectious agents, modifying the treatment when appropriate and it provides a simple yet effective tool to establish the efficacy of therapy.

Hospital-Acquired Infection Diagnostics Market, By Infection Type

• Bloodstream Infection
• Urinary Tract Infection
• Surgical Site Infection
• Pneumonia/lower Respiratory Tract Infection
• Others

Based on Infection Type, the market is segmented into Bloodstream Infection, Urinary Tract Infection, Surgical Site Infection, Pneumonia/lower Respiratory Tract Infection, and Others. Among the different types of Infection, urinary tract infection is the most common Hospital-Acquired Infection Diagnostics Market of UTI is expected to lead the market share. But the industry for diagnosis of pneumonia as a nosocomial infection is anticipated to witness the highest growth in the coming years.

Hospital-Acquired Infection Diagnostics Market, By Application

• Disease Testing
• Drug Resistance Testing

Based on Application, the market is segmented into Disease Testing and Drug Resistance Testing. The drug resistance testing segment held the largest share in 2020 and is expected to remain the market leader in the coming years.

Hospital-Acquired Infection Diagnostics Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Geography, the Global Hospital-Acquired Infection Diagnostics Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America held the largest share in 2020. This is because of the increase in the geriatric population in the region along with the adoption of advanced diagnostic treatment.

Asia Pacific is expected to witness the fastest growth rate and highest CAGR due to the growing awareness about hospital-acquired infections and improvement in healthcare conditions in developing nations. The rising incidence of HAI conditions in countries such as China and India is likely to boost the growth of the Global Hospital-Acquired Infection Diagnostics Market.

Key Players

The “Global Hospital-Acquired Infection Diagnostics Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Cantel Medical, Getinge Group, Steris Corporation, 3M Company, Synergy Health Plc, Kimberly-Clark Corporation, Advanced Sterilization Products, Sterigenics International LLC, Belimed AG, and Becton, Dickinson and Company.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into Active, Cutting Edge, Emerging, and Innovators categories. 

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Hospital-Acquired Infection Diagnostics Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the Global Hospital-Acquired Infection Diagnostics Market, gauge the attractiveness of a certain sector, and assess investment possibilities.